OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Showing 24 citing articles:
Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis
Wanqian Xu, Weigang Ren, Tongxin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 18
Wanqian Xu, Weigang Ren, Tongxin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 18
Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 15
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 15
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis
Mahya Shabani, Parnian Shobeiri, Shadi Nouri, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Mahya Shabani, Parnian Shobeiri, Shadi Nouri, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study
Jennifer H. Ku, Lina S. Sy, Lei Qian, et al.
Vaccine (2023) Vol. 41, Iss. 24, pp. 3636-3646
Open Access | Times Cited: 13
Jennifer H. Ku, Lina S. Sy, Lei Qian, et al.
Vaccine (2023) Vol. 41, Iss. 24, pp. 3636-3646
Open Access | Times Cited: 13
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1706-1706
Open Access | Times Cited: 10
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1706-1706
Open Access | Times Cited: 10
Cohort profile:Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 16
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 16
Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells
Javier Campos, Courtney Fernandez Petty, Marina Mazur, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 324, Iss. 4, pp. L493-L506
Open Access | Times Cited: 7
Javier Campos, Courtney Fernandez Petty, Marina Mazur, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 324, Iss. 4, pp. L493-L506
Open Access | Times Cited: 7
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
(2023)
Open Access | Times Cited: 6
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
(2023)
Open Access | Times Cited: 6
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5–11 years old children with prior COVID-19
Costanza Di Chiara, Anna Cantarutti, Maria Raffaella Petrara, et al.
Vaccine (2023) Vol. 42, Iss. 2, pp. 263-270
Open Access | Times Cited: 6
Costanza Di Chiara, Anna Cantarutti, Maria Raffaella Petrara, et al.
Vaccine (2023) Vol. 42, Iss. 2, pp. 263-270
Open Access | Times Cited: 6
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)
Marc Hilhorst, Fréderike J. Bemelman, Annette Bruchfeld, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 8, pp. 1807-1816
Closed Access | Times Cited: 4
Marc Hilhorst, Fréderike J. Bemelman, Annette Bruchfeld, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 8, pp. 1807-1816
Closed Access | Times Cited: 4
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination
Caroline De Bouver, Jason Bouziotis, Veerle Wijtvliet, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Caroline De Bouver, Jason Bouziotis, Veerle Wijtvliet, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1
COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States
Kira Zhi Hua Lai, Stuart Greenstein, Rajesh Govindasamy, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2255-2283
Open Access | Times Cited: 1
Kira Zhi Hua Lai, Stuart Greenstein, Rajesh Govindasamy, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2255-2283
Open Access | Times Cited: 1
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
Puran Chen, Peter Bergman, Ola Blennow, et al.
EBioMedicine (2024) Vol. 109, pp. 105385-105385
Closed Access | Times Cited: 1
Puran Chen, Peter Bergman, Ola Blennow, et al.
EBioMedicine (2024) Vol. 109, pp. 105385-105385
Closed Access | Times Cited: 1
Immunologic Response to SARS-CoV-2 Vaccination in Pediatric Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Elpida Emmanouilidou-Fotoulaki, Vasiliki Karava, John Dotis, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1080-1080
Open Access | Times Cited: 2
Elpida Emmanouilidou-Fotoulaki, Vasiliki Karava, John Dotis, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1080-1080
Open Access | Times Cited: 2
Boosting Vaccine Response in Autoimmune Rheumatic Disease Patients With Inadequate Seroconversion: An Analysis of the Immunogenicity of Vector-Based and Inactivated Vaccines
Anuroopa Vijayan, Aswathy Sukumaran, Sara R. Jones, et al.
Cureus (2024)
Open Access
Anuroopa Vijayan, Aswathy Sukumaran, Sara R. Jones, et al.
Cureus (2024)
Open Access
Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina
Yantorno Silvina, Curciarello Renata, Rizzo Gastón, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111091-111091
Closed Access
Yantorno Silvina, Curciarello Renata, Rizzo Gastón, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111091-111091
Closed Access
A randomized trial of at-home COVID-19 tests, telemedicine, and rapid prescription delivery for immunocompromised individuals
Julia Moore Vogel, Ting-Yang Hung, Erin Coughlin, et al.
Research Square (Research Square) (2024)
Open Access
Julia Moore Vogel, Ting-Yang Hung, Erin Coughlin, et al.
Research Square (Research Square) (2024)
Open Access
Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
Javier Campos, Courtney Fernandez Petty, Marina Mazur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Javier Campos, Courtney Fernandez Petty, Marina Mazur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients
Agata Błaszczuk, Dominika Sikora, Jacek Kiś, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 770-770
Open Access
Agata Błaszczuk, Dominika Sikora, Jacek Kiś, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 770-770
Open Access
SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 7
Closed Access
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 7
Closed Access
Managing acute COVID-19 in immunocompromised pediatric patients
Federico Mercolini, Nicoletta Abram, Simone Cesaro
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 349-357
Closed Access
Federico Mercolini, Nicoletta Abram, Simone Cesaro
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 349-357
Closed Access
Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
Pankti Mehta, Sakir Ahmed, Padmanabha Shenoy, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 12, pp. e817-e818
Open Access
Pankti Mehta, Sakir Ahmed, Padmanabha Shenoy, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 12, pp. e817-e818
Open Access
